Biotech Stock Roundup: Amgen Gets FDA Nod for Kanjinti, Regeneron Presents DataZacks Investment Research • 06/19/19
Regeneron Pharmaceuticals, Inc. (REGN) CEO Leonard Schleifer on Q1 2019 Results - Earnings Call TranscriptSeeking Alpha • 05/07/19
Biotech Giant Regeneron Slides As Earnings, Sales Lag ExpectationsInvestors Business Daily • 05/07/19